None listed
Conditions
Sponsors
Yonsei University Health System, Gangnam Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Men or women between the ages of 20 and 70 2) Subjects who have voluntarily decided to participate after hearing the explanation of the clinical trial process and signed the consent form 3) All subjects requiring ultrasound endoscopy 4) Subjects with class I or II in the American Society of Anesthesiology (ASA) risk assessment
Exclusion criteria
Exclusion criteria: 1) Pregnant woman 2) Those who are susceptible to remimazolam, propofol or benzodiazepine drugs (midazolam), or those who are susceptible to eggs, beans, etc 3) subjects undergoing adrenocortical or chronic steroid therapy or porphyria 4) Subjects who are expected to have difficulty with airway intubation (subjects who have difficulty opening their mouths wide or have a thick neck and short neck) 5) a subject diagnosed with sleep apnea 6) Subjects with a history of reported risk cases during sedative endoscopy in the past 7) Subjects with severe renal disease (serum creatinine >2 mg/dL) 8) Subjects with severe heart disease (subjects with NYHA class III or IV) 9) subjects who wish to receive an endoscopy without sincerity 10) Subjects who cannot or are not willing to prepare an automatic test protocol or who do not agree to provide information; 11) Subjects whose oxygen saturation is less than 90% or less than 95% despite the oxygen supply of 2 L/min 12) Subjects with an underlying systolic blood pressure of less than 80 mmHg
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of cardiopulmonary hazards at all times during the procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedure time, recovery time, patient satisfaction, operator satisfaction, total remimazolam administered and propofol dose | — |
Countries
Korea, Republic of
Contacts
Public ContactDongwook Oh
Asan Medical Center
Outcome results
None listed